Perinatal tuberculosis and HIV-1: considerations for resource-limited settings

Lancet Infect Dis. 2004 Mar;4(3):155-65. doi: 10.1016/S1473-3099(04)00939-9.

Abstract

Tuberculosis is the commonest HIV-1-related disease and the most frequent cause of mortality in young women in endemic regions. Tuberculosis and HIV-1 are independent risk factors for maternal mortality and adverse perinatal outcomes, and in combination have a greater impact on these parameters than their individual effects. In referral health centres in southern Africa around one-sixth of all maternal deaths are due to tuberculosis/HIV-1 coinfection. One-third (37%) of HIV-1-infected mothers with tuberculosis are severely immunocompromised, with CD4 counts of fewer than 200 cells/microL compared with 14-19% in mothers recruited into major mother-to-child intervention trials in Europe. Babies born to mothers with tuberculosis/HIV-1 also have higher rates of prematurity, low birthweight, and intrauterine growth restriction. Transmission rates of HIV-1 from mother to infant are around 25-45% in resource-limited settings, while that for mother-to-child-transmission of tuberculosis is 15% within 3 weeks of birth. We highlight this emergent problem, and discuss the dilemmas associated with diagnosis and management of pregnant HIV-1-infected mothers with tuberculosis, and their newborn babies.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Africa, Southern
  • Anti-Retroviral Agents / adverse effects
  • Anti-Retroviral Agents / therapeutic use
  • Antitubercular Agents / adverse effects
  • Antitubercular Agents / therapeutic use
  • Female
  • HIV Infections / drug therapy
  • HIV Infections / mortality
  • HIV Infections / transmission*
  • HIV-1*
  • Humans
  • Infant Mortality
  • Infant, Newborn
  • Infectious Disease Transmission, Vertical / prevention & control*
  • Maternal Mortality
  • Perinatal Care
  • Pregnancy
  • Pregnancy Complications, Infectious* / drug therapy
  • Pregnancy Complications, Infectious* / mortality
  • Pregnancy Outcome
  • Risk Factors
  • Tuberculosis / drug therapy
  • Tuberculosis / mortality
  • Tuberculosis / transmission*
  • Viral Load

Substances

  • Anti-Retroviral Agents
  • Antitubercular Agents